Your browser is no longer supported. Please, upgrade your browser.
Settings
PRGO Perrigo Company plc daily Stock Chart
PRGO [NYSE]
Perrigo Company plc
IndexS&P 500 P/E- EPS (ttm)-1.91 Insider Own0.20% Shs Outstand141.77M Perf Week-3.70%
Market Cap12.95B Forward P/E10.07 EPS next Y9.07 Insider Trans-2.68% Shs Float136.61M Perf Month4.09%
Income-272.50M PEG- EPS next Q1.99 Inst Own79.20% Short Float3.97% Perf Quarter-5.93%
Sales5.68B P/S2.28 EPS this Y-95.80% Inst Trans-1.09% Short Ratio2.21 Perf Half Y-36.63%
Book/sh68.77 P/B1.33 EPS next Y10.52% ROA-1.10% Target Price117.63 Perf Year-52.24%
Cash/sh- P/C- EPS next 5Y8.04% ROE-2.10% 52W Range84.72 - 197.59 Perf YTD-36.71%
Dividend0.58 P/FCF32.13 EPS past 5Y-59.80% ROI0.80% 52W High-53.77% Beta0.29
Dividend %0.63% Quick Ratio1.00 Sales past 5Y0.10% Gross Margin39.70% 52W Low7.81% ATR2.38
Employees13242 Current Ratio1.40 Sales Q/Q31.80% Oper. Margin-0.40% RSI (14)44.94 Volatility2.39% 2.48%
OptionableYes Debt/Eq0.66 EPS Q/Q-246.70% Profit Margin-3.80% Rel Volume0.67 Prev Close90.78
ShortableYes LT Debt/Eq0.60 EarningsAug 04 BMO Payout- Avg Volume2.46M Price91.34
Recom2.80 SMA20-1.32% SMA50-3.58% SMA200-28.05% Volume1,640,754 Change0.62%
Jul-22-16Upgrade Deutsche Bank Hold → Buy $115
Jun-20-16Downgrade Argus Buy → Hold
Apr-26-16Reiterated RBC Capital Mkts Sector Perform $140 → $109
Apr-26-16Reiterated Barclays Overweight $180 → $120
Apr-25-16Downgrade Wells Fargo Outperform → Market Perform
Apr-25-16Downgrade BofA/Merrill Buy → Underperform
Feb-22-16Downgrade Goldman Neutral → Sell
Feb-19-16Initiated Wells Fargo Outperform
Feb-19-16Downgrade B. Riley & Co. Buy → Neutral $239 → $146
Jan-21-16Initiated Barclays Overweight $180
Dec-10-15Upgrade Argus Hold → Buy $170
Dec-03-15Initiated Morgan Stanley Equal-Weight
Nov-24-15Reiterated B. Riley & Co. Buy $229 → $237
Nov-18-15Resumed JP Morgan Neutral
Nov-16-15Upgrade UBS Neutral → Buy $200
Oct-23-15Reiterated B. Riley & Co. Neutral $218 → $229
Jun-03-15Reiterated B. Riley & Co. Neutral $195 → $216
Apr-27-15Downgrade B. Riley & Co. Buy → Neutral
Apr-22-15Reiterated B. Riley & Co. Buy $189 → $195
Apr-10-15Downgrade Argus Buy → Hold
Jul-27-16 05:41PM  Teva, Allergan win U.S. antitrust approval for generics deal Reuters
11:08AM  Factors That Could Lead to More Growth for Acthar
07:59AM  Perrigo Company plc To Release Second Quarter Calendar Year 2016 Results On August 10, 2016 PR Newswire
Jul-26-16 12:52PM  Jerome Dodson Comments on Perrigo
12:41PM  Jerome Dodson's Parnassus Fund 2nd Quarter Commentary
Jul-22-16 12:54PM  Perrigo upgraded by Deutsche Bank
07:33AM  It's Time to Sell These 5 Big Stocks This Summer
Jul-20-16 08:55PM  Perrigo Announces Leadership Change in Rx Pharmaceuticals Segment PR Newswire
Jul-19-16 02:48PM  Perrigo Co. Plc Value Analysis (NYSE:PRGO) : July 19, 2016
08:22AM  5 Big Pharma Stocks Struggling to Raise Their Dividends at Motley Fool
Jul-18-16 08:51AM  Perrigo Announces FDA Final Approval And Launch Of The Store Brand Equivalent To Zegerid OTC® Capsules PR Newswire
Jul-16-16 11:06AM  PERRIGO SHAREHOLDER JULY 18 DEADLINE: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces the Filing of a Securities Class Action Lawsuit Against Perrigo Company plc; Encourages Investors to Contact the Firm PR Newswire
Jul-15-16 10:07PM  PERRIGO 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Perrigo Company plc - PRGO GlobeNewswire
07:48PM  July 18 Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming Deadline in the Class Action Lawsuit Against Perrigo Company plc Business Wire
02:41PM  Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Perrigo Company plc Investors and Encourages Investors to Contact the Firm Business Wire
09:00AM  UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Perrigo Company plc of Class Action Lawsuit and a Lead Plaintiff Deadline of July 18, 2016 PRGO GlobeNewswire
Jul-14-16 12:41PM  SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Perrigo Company plc and Encourages Investors with Losses to Contact the Firm Business Wire
09:13AM  Valeant's Ex-CEO Michael Pearson Sells Nearly $100 Million in Company Stock at The Wall Street Journal
12:20AM  Valeants Ex-CEO Michael Pearson Sells Nearly $100 Million in Company Stock at The Wall Street Journal
Jul-13-16 07:36PM  Valeants former CEO dumped $100 million in stock in past 2 weeks at MarketWatch
01:48PM  David Rolfe Comments on Perrigo
10:30AM  The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Perrigo Company plc Investors and Encourages Investors to Contact the Firm Business Wire
08:52AM  Perrigo Co. Plc breached its 50 day moving average in a Bullish Manner : PRGO-US : July 13, 2016
Jul-12-16 04:27PM  Pricing Stress may Weigh on Generic Drugmakers Ahead of Q2 Earnings
01:42PM  David Rolfe's Wedgewood Partners 2nd Quarter 2016 Client Letter
11:59AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Perrigo Company plc (PRGO) & Lead Plaintiff Deadline: July 18, 2016 Accesswire
Jul-11-16 12:29PM  APPROACHING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Perrigo Company plc and Reminds Investors with Losses to Contact the Firm Business Wire
11:14AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Perrigo Company plc of Class Action Lawsuit and a Lead Plaintiff Deadline of July 18, 2016 Business Wire
Jul-08-16 08:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Perrigo Company plc of Class Action Lawsuit and Upcoming Deadline PRGO GlobeNewswire
Jul-06-16 01:04AM  [$$] Valeants New CEO Brings Familiar Prescription at The Wall Street Journal
Jul-05-16 06:22PM  [$$] Valeant's New CEO Brings Familiar Prescription at The Wall Street Journal
04:29PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Perrigo Company plc and Reminds Investors with Losses to Contact the Firm Business Wire
03:20PM  Bill Ackman's Pershing Square Fund Goes Into the Red
10:45AM  PRGO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Perrigo Company plc and a Lead Plaintiff Deadline of July 18, 2016 Business Wire
Jul-01-16 10:13PM  INVESTOR NOTICE: Goldberg Law PC Announces Securities Class Action Lawsuit against Perrigo Company plc and Encourages Investors with Losses to Contact the Firm Business Wire
10:07PM  PERRIGO SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Perrigo Company plc - PRGO PR Newswire
05:33PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Perrigo Company plc of Class Action Lawsuit and Upcoming Deadline - PRGO PR Newswire
10:43AM  Alternate Dosage Forms Are Expected to Drive Akorns Growth in 2016
Jun-29-16 04:43PM  INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Perrigo Company plc and a Lead Plaintiff Deadline of July 18, 2016 - PRGO PR Newswire
Jun-27-16 06:38AM  PERRIGO CO PLC Files SEC form 8-K, Other Events
Jun-24-16 11:30PM  DEADLINE ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Perrigo Company plc and Reminds Investors with Losses to Contact the Firm Accesswire
09:15PM  DEADLINE ALERT: Brower Piven Reminds Shareholders of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess of $100,000 From Investment In Perrigo Company plc To Contact The Firm Business Wire
11:02AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Perrigo Company plc of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 18, 2016 Business Wire
Jun-23-16 05:05PM  SHAREHOLDER NOTICE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Perrigo Company plc and Reminds Investors with Losses to Contact the Firm Business Wire
02:24PM  INVESTOR ALERT: Investigation of Perrigo Company plc Announced by Law Offices of Howard G. Smith Business Wire
05:30AM  DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Perrigo Company plc and Reminds Investors with Losses to Contact the Firm Business Wire
Jun-22-16 08:52AM  Research Report Initiated on Select Healthcare Equities
04:04AM  What Do Analysts Think about Valeant?
Jun-21-16 04:57PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Perrigo Company plc and Certain Officers PRGO GlobeNewswire
08:29AM  Perrigo Announces FDA Clearance And Launch Of Non-GMO* Infant Formulas For The U.S. Store Brand Market PR Newswire
Jun-20-16 05:32PM  Perrigo Sells Vitamins Business to IVC
10:44AM  SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Perrigo Company plc and a Lead Plaintiff Deadline of July 18, 2016 Business Wire
09:05AM  Morning Movers: Under Armour Gains on Upgrade; Spirit Airlines Flies at Barrons.com
07:58AM  Perrigo Divests Vitamins, Minerals & Supplements Business To IVC PR Newswire
Jun-17-16 10:07PM  PERRIGO SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Perrigo Company plc Business Wire
03:38PM  PERRIGO CO PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Jun-16-16 04:41PM  Perrigo Announces FDA Approval Of The Generic Version Of Ofirmev® Acetaminophen Injection PR Newswire
10:57AM  Looking for Relief From Biotech Pain
08:49AM  Perrigo Company to Present at the Oppenheimer 16th Annual Consumer Conference PR Newswire
Jun-15-16 09:31PM  Trending Now: PRGO -9.19%
02:23PM  Perrigo Deal Rumors Are Just Smoke at Bloomberg
02:18PM  Fed punts and leaves interest rates unchanged
01:32PM  Perrigo (PRGO) Stock Retreats as Takeover Speculation Fades
01:18PM  IMPORTANT SHAREHOLDER NOTICE: Goldberg Law PC Announces An Investigation of Claims Against Perrigo Company plc And Advises Investors With Losses To Contact The Firm Business Wire
12:32PM  Perrigo: 'All We Hear is Noise' at Barrons.com
12:09PM  Why Perrigo Company & Four Other Stocks Are Making Headlines on Wednesday at Insider Monkey
10:27AM  INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving Perrigo Company plc and a Lead Plaintiff Deadline of July 18, 2016 - PRGO GlobeNewswire
09:51AM  Stocks Open Higher Ahead Of Fed; Factory Data Mixed
09:20AM  Perrigo Rises Further as Takeover Rumor Swirls
09:03AM  The Market In 5 Minutes: Janet Yellen, Exact Sciences And Some Graduation Advice
08:06AM  Perrigo Co. Plc breached its 50 day moving average in a Bullish Manner : PRGO-US : June 15, 2016
01:36AM  Perrigo Said to Be Nearing Deal at Bloomberg
Jun-14-16 04:43PM  Perrigo (PRGO) Stock Spiked After Report of Takeover +9.16%
04:04PM  Perrigo Shares Gain After Report Drugmaker Is Close to Deal at Bloomberg
Jun-13-16 06:00PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Perrigo Company plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit PRGO GlobeNewswire
02:14PM  Valeant Tries to Fix 'Speed Bumps' in Walgreens Deal
02:02PM  Will Endo (ENDP) Stock Be Helped by Mizuho Upgrade?
10:55AM  Specialty Pharma: Perrigo and Endo Would Be 'Logical' Spin-Merger Partners, Probably Won't Happen at Barrons.com
09:01AM  Perrigo Confirms First To File Patent Challenge For Generic Version Of Picato® Gel (0.015% And 0.05%) PR Newswire
Jun-10-16 10:43AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Perrigo Company plc of Class Action Lawsuit and a Lead Plaintiff Deadline of July 18, 2016 PRGO GlobeNewswire
Jun-09-16 09:07AM  What Caused Alexion Pharmaceuticals Fall?
Jun-07-16 03:31PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Perrigo Company plc - PRGO Accesswire
01:50AM  Perrigo Co. Plc :PRGO-IL: Earnings Analysis: Q1, 2016 By the Numbers : June 7, 2016
Jun-06-16 08:23PM  INVESTOR NOTICE: Khang & Khang LLP Announces an Investigation of Claims Against Perrigo Company plc And Advises Investors to Contact the Firm Business Wire
02:49PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Perrigo Company plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 18, 2016 - PRGO Accesswire
Jun-04-16 03:05AM  4 Long Ideas From the London Value Investor Conference at Insider Monkey
Jun-03-16 10:55PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Claims Against Perrigo Company plc And Advises Investors to Contact the Firm Business Wire
10:07PM  PERRIGO SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Perrigo Company plc - PRGO Marketwired
12:30PM  Safirstein Metcalf LLP Announces That a Class Action Lawsuit Has Been Filed Against Perrigo Company plc - PRGO GlobeNewswire
11:34AM  Glancy Prongay & Murray Commences Investigation on Behalf of Perrigo Company plc Investors Business Wire
Jun-02-16 08:00PM  INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Perrigo Company plc to Contact Brower Piven before the Lead Plaintiff Deadline in Class Action Lawsuit Business Wire
Jun-01-16 01:25PM  Vertex Receives FDA Nod for Priority Review of Orkambi
07:00AM  Ultimate Stock-Pickers: Top 10 Buys and Sells at Morningstar
May-31-16 02:01AM  Perrigo Announces FDA Approval And Launch Of The Store Brand Equivalent To Flonase® PR Newswire
May-27-16 11:53AM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Perrigo Company plc of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 18, 2016 -- PRGO Marketwired
May-25-16 10:55AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Perrigo Company plc - PRGO PR Newswire
May-24-16 10:10PM  Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Perrigo Company plc to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit PRGO GlobeNewswire
06:27PM  Robbins Arroyo LLP: Perrigo Company plc (PRGO) Misled Shareholders According to a Recently Filed Class Action Business Wire
03:31PM  ETFs with exposure to Perrigo Co. Plc : May 24, 2016
03:00PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Perrigo Company plc (PRGO) and Lead Plaintiff Deadline July18, 2016 Accesswire
Perrigo Company plc, together with its subsidiaries, develops, manufactures, markets, and distributes over-the-counter (OTC) consumer goods and pharmaceutical products worldwide. The company operates through Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx), Specialty Sciences, and Other segments. The CHC segment offers OTC products in various categories, including analgesics, cough/cold/allergy/sinus, gastrointestinal, infant nutritional, smoking cessation, animal health, feminine hygiene, diabetes and dermatological care, diagnostic, scar management, and other healthcare products, as well as vitamins, minerals, and dietary supplements (VMS); and contract manufacturing services. It serves retail drug, supermarket, mass merchandise chains, and wholesalers through sales force and industry brokers. The BCH segment provides branded OTC products in the natural health and VMS; cough, cold, flu, and allergy; personal care and derma-therapeutics; lifestyle; pain relief, nasal decongestants, and cold sore management; and anti-parasite areas, as well as offers generic pharmaceutical products. It serves pharmacies, drug, and grocery stores through pharmacy sales force, as well as a network of pharmacists. The Rx segment offers generic and specialty pharmaceutical prescription drugs in various dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, women's health products, oral solid dosage forms, and oral liquid formulations; and ORx products. It serves wholesalers; retail drug, supermarket, and mass merchandise chains; hospitals; and pharmacies. The Specialty Sciences segment offers Tysabri to treat multiple sclerosis. The Other segment offers active pharmaceutical ingredients used by generic and branded pharmaceutical companies. The company was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JANDERNOA MICHAEL JDirectorMay 04Option Exercise95.7092488,4278,774May 06 04:23 PM
MORRIS HERMAN JRDirectorMay 04Option Exercise95.7092488,4275,055May 06 04:23 PM
FOUSE JACQUALYN ADirectorMay 04Option Exercise95.7092488,4274,360May 06 04:24 PM
COHEN GARY MDirectorMay 04Option Exercise95.7092488,42713,795May 06 04:24 PM
Yanai ShlomoDirectorMay 04Option Exercise95.7092488,427924May 06 04:22 PM
BRLAS LAURIEDirectorMay 04Option Exercise95.7092488,42710,901May 06 04:22 PM
KUNKLE GARY K JRDirectorMay 04Option Exercise95.7092488,42726,131May 06 04:23 PM
Hoffing Ellen RandiDirectorMay 04Option Exercise95.7092488,4279,528May 06 04:24 PM
Brown Judy LExecutive VP & CFOApr 13Option Exercise113.772,776315,82513,924Apr 14 03:38 PM
Brown Judy LExecutive VP & CFOApr 13Sale126.222,776350,38712,429Apr 14 03:38 PM
JANDERNOA MICHAEL JDirectorMar 18Option Exercise16.775,81497,5018,611Mar 22 04:31 PM
JANDERNOA MICHAEL JDirectorMar 18Sale128.2976197,6297,850Mar 22 04:31 PM
Kochan SharonEVP, GM InternationalMar 02Sale125.281,490186,6675,883Mar 04 02:43 PM
Brown Judy LExecutive VP & CFOFeb 24Option Exercise113.772,776315,82513,924Feb 26 03:07 PM
Brown Judy LExecutive VP & CFOFeb 24Sale123.732,776343,47412,429Feb 26 03:07 PM
PERRIGO Co plc10% OwnerFeb 17Buy8.00125,0001,000,0002,908,067Feb 18 05:50 PM
Brown Judy LExecutive VP & CFOJan 06Option Exercise83.1227,7372,305,62426,518Jan 08 03:27 PM
Brown Judy LExecutive VP & CFOJan 06Sale142.4127,7373,950,07512,429Jan 08 03:27 PM
PAPA JOSEPH CCEODec 28Option Exercise58.8210,183598,964129,598Dec 30 03:18 PM
PAPA JOSEPH CCEODec 28Sale147.0710,1831,497,579119,415Dec 30 03:18 PM
Farrington ThomasEVP and CIONov 30Sale151.0335052,8611,194Dec 02 09:29 AM
Gottfried RanDirectorNov 19Option Exercise100.842,726274,89015,454Nov 23 04:17 PM
Gottfried RanDirectorNov 19Sale154.342,726420,72212,728Nov 23 04:17 PM
MORRIS HERMAN JRDirectorNov 18Sale155.6455085,602850Nov 20 07:35 PM
KUNKLE GARY K JRDirectorNov 13Option Exercise146.901,929283,37026,133Nov 17 04:57 PM
JANDERNOA MICHAEL JDirectorNov 13Option Exercise146.901,929283,3702,797Nov 17 04:57 PM
BRLAS LAURIEDirectorNov 13Option Exercise146.901,929283,37010,903Nov 17 04:58 PM
Hoffing Ellen RandiDirectorNov 13Option Exercise146.901,929283,3709,530Nov 17 04:56 PM
FOUSE JACQUALYN ADirectorNov 13Option Exercise146.901,929283,3704,362Nov 17 04:56 PM
COHEN GARY MDirectorNov 13Option Exercise146.901,929283,37013,797Nov 17 04:56 PM
MORRIS HERMAN JRDirectorNov 13Option Exercise146.901,929283,3705,057Nov 17 04:57 PM
O'Connor DonalDirectorNov 13Option Exercise146.901,929283,3702,173Nov 17 04:57 PM
GIBBONS DAVID TDirectorNov 04Option Exercise162.291,929313,05715,104Nov 05 04:16 PM
Gottfried RanDirectorNov 04Option Exercise162.291,929313,05713,654Nov 06 05:22 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyAug 25Sale181.371,737315,0400Aug 27 03:32 PM
KINGMA TODD WExecutive VP, General CounselAug 25Sale181.371,715311,05010,320Aug 27 03:32 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyAug 24Option Exercise114.604,468512,0314,131Aug 25 06:21 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyAug 24Sale177.684,468793,8701,737Aug 25 06:21 PM
Jamison Scott FExecutive Vice President PBMAug 21Option Exercise186.89552103,1635,379Aug 25 06:21 PM
Stewart Michael RobertSr. VP Global Human ResourcesAug 21Option Exercise186.89552103,1631,398Aug 25 06:21 PM
Shah JatinSr VP & Chief Scientific OfficAug 21Option Exercise186.89552103,1634,619Aug 25 06:22 PM
Needham JeffreyEVP, GM Consumer HealthcareAug 21Option Exercise186.89967180,7237,646Aug 25 06:20 PM
Kochan SharonEVP, GM InternationalAug 21Option Exercise186.89967180,7237,731Aug 25 06:20 PM
PAPA JOSEPH CPresident and CEOAug 21Option Exercise186.897,3651,376,445123,234Aug 25 06:21 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyAug 21Option Exercise186.891,022191,0022,223Aug 25 06:21 PM
Farrington ThomasSenior VP and CIOAug 21Option Exercise186.89552103,1631,719Aug 25 06:19 PM
Boothe DouglasEVP & GM Perrigo PharmaAug 21Option Exercise186.8939573,822951Aug 25 06:19 PM
KINGMA TODD WExecutive VP, General CounselAug 21Option Exercise186.891,409263,32812,686Aug 25 06:19 PM
Yu LouisExecutive VP Global QualityAug 21Option Exercise186.89552103,1636,327Aug 25 06:20 PM
Brown Judy LExecutive VP & CFOAug 21Option Exercise186.892,578481,80213,621Aug 25 06:20 PM